chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient felt light headed around 1 hour after receiving vaccination. Nurse practitioner evaluated patient and took vital signs: BP 132/86, repeat 15 minutes later after patient given crackers and water was 115/57. Patient felt better and left facility.
She experienced lethargy; vomiting; low grade fever; This is a spontaneous report from a contactable other health care professional. This nurse reported for a female patient (grandmother). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on Jan2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 06Feb2021, the patient experienced she experienced lethargy and low grade fever. Caller would like to know if it is safe to receive the 2nd dose of the covid vaccine with symptoms of lethargy, vomiting and low-grade fever. Caller does not wish to report at this time. Caller was reporting on behalf of her grandmother who is due to receive the 2nd dose of the covid vaccine tomorrow. She experienced lethargy, vomiting on Saturday and a low grade fever. Caller does not believe this is due to the vaccine however since the 1st dose was closer to 3 weeks ago. The clinical outcome of the events was reported as unknown.  Follow-up attempts completed. No further information expected.
diagnosed with Bulbous Pemphigoid (autoimmune disease) a little more than one month later.
PATIENT STSTES SHE BAGAN TO FEEL COLD THE EVENING OF 2/21, THEN INTO SATURDAY MORNING/EARLY AFTERNOON THE PATIENT BEGAN TO EXPERIENCE REDNESS, SWELLING AND PAIN IN HER LEFT LOWER ARM BELOW THE INJECTION SITE.  THE PATIENT PRESENTED TO THE PHARMACY ON 2/23 AND S=IT WAS SUGGESTED SHE FOLLOW-UP WITH HER PROVIDER ON  MONDAY, 2/24.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown ages and gender. The pharmacist reported that on an unknown dates at least a half-dozen patients were vaccinated with a dose of ZOSTAVAX (route, dose and lot number not provided). On an unknown dates the patients experienced injection site reaction. The outcome of injection site reaction was unknown for all the patients. This is one of several reports from the same source. Additional information has been requested.
Noticed 1x4mm blister about 3cm towards (L) side of injection site when GARDASIL was given.
Metallic taste; Fatigue; Injured hip while jogging; Painful; This spontaneous case was reported by a consumer and describes the occurrence of JOINT INJURY (Injured hip while jogging), PAIN (Painful), DYSGEUSIA (Metallic taste) and FATIGUE (Fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Panuveitis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2020, the patient experienced JOINT INJURY (Injured hip while jogging) and PAIN (Painful). On an unknown date, the patient experienced DYSGEUSIA (Metallic taste) and FATIGUE (Fatigue). At the time of the report, JOINT INJURY (Injured hip while jogging) had not resolved, PAIN (Painful) outcome was unknown and DYSGEUSIA (Metallic taste) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for the events of INJURED HIP WHILE JOGGING, METALLIC TASTE and FATIGUE with HUMIRA(ADALIMUMAB) was no reasonable possibility. The reporter's causality for the event of PAINFUL was not provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Enlarged lymph nodes around collar bone, exquisitely painful, headaches, joint pain, nerve pain, nausea, heart palpitations.  The lymph nodes resolved after 7-10 days but the other symptoms are still ongoing.
Hives on legs...by the next morning it was all over her body.  By the third day my daughter was vomiting.
Strong cough about two and a half hours after vaccine. Started to feel lightheaded and short of breath shortly after.  Took 25mg of Benadryl and two puffs of ProAir rescue inhaler. Was given epinephrine, Xyzal, 4 more puffs of ProAir rescue inhaler, and one inhalation of Breo 100mg. Symptoms subsided after treatment and I went back to normal health.
VISUAL DISTURBANCE - SEEING NON-EXISTENT ''PATTERNS'' IN PLAIN PAINTWORK ON WALLS AT HOME; ACUTE INSOMNIA, NECESSITATING PRESCRIPTION SLEEPING PILLS, PERSISTING EVER SINCE DATE OF VACCINE; COGNITIVE IMPAIRMENT - UNFOCUSED THINKING, CONFUSION, SPEECH ERRORS (DID NOT DRIVE CAR FOR 3 WEEKS); TINNITUS (PERSISTENT);GASTRIC DISTURBANCES (NAUSEA, DIARRHOEA, CONSTIPATION, ABDOMINAL NOISES, PERSISTENT);  HEADACHE - DAILY, PERSISTENT; PAINFUL SHOULDER MUSCLES, PERSISTENT; PAINFUL DELTOID MUSCLE WHERE INJECTION ADMINISTERED, PERSISTENT.
10/11/2022- present to ED from SNF, for AMS. Covid + test. Placed on 3L NC 87% on RA. . CXR-no evidence of acute cardiopulmonary disease. UTI. Afebrile. Start Remdesivir, decadron, doxy and Rocephin. New liver mass on CT. Admit AMS.  10/14/2022- Maintaining 02 on RA. WBC-WNL.  10/16/2022- Repeat CT mass-cholecystitis with liver abscess. Finished remdesivir. contine with decadron and rocephin. Spo2 above 95% on RA.  10/20/2022-liver abscess drained.  10/25/2022-Cont. IV rocephin and doxy, completed remdesivir and on RA.  10/27/2022- D/c to SNF.
platelets became unstable, platelets were extremely low (under 20k)  for several months despite treatment.
Conjunctivitis, Antibiotic eye drops Tobramycin Ophthalmic Solution, USP 0.3% 5mL Use 1-2 drops right eye every 2 hours for first 2 days, 1-2 drops right eye every 4 hours for 5 days, Return if symptoms worsen
This spontaneous report as received from a physician refers to a 14 years old male patient. The physician reported the patient "fainted for a few seconds" after administration of his first dose of GARDASIL (lot# was unknown) 2 months ago about in June, 2012. The patient sought medical attention in office and got no treatment. None lab diagnostics was performed. The patient fully recovered without requiring treatment. Additional information is not expected.
felt like i had the flu the next day. Ached all over no energy, stayed in bed all day
Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022; Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022) to be not related. No further causality assessment was provided for PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 07-Mar-2022, dose administered after 30 days use by date on 11 -Apr-2022).    Concomitant product use was not provided by the reporter. Vaccine was received in refrigerator on 07-Mar-2022 in appropriate temperature (2-8 Celsius). Vaccine was administered to patient 5 days past the 30 day time in refrigerator. Vial did not undergo any temperature excursions. The patient received  Moderna vaccine  Booster on 11-Apr-2022. Vaccine was given beyond use date. The event did not cause the patient to seek medical care. There were no any other potential causes. Treatment information was not provided.
pains and body aches, nonproductive cough Fever of 102.2 on arrival to ED.
I contracted COVID-19 on 1/17/2022 the day after his Treximet infusion with symptoms of headache, shortness of breath, congestion, fever of 103.5, myalgia, altered sense of taste, and called the ER two days later and was advised to come in. Was informed he was out of the monoclonal antibodies treatment window. The shortness of breath and chest tightness increased to the point of being admitted to the hospital. I was on 50L of oxygen by the 3rd day of hospital stay, and was transferred via life flight to the ICU where he stayed for 5 days before being moved to a regular room after 2 days. I was given monoclonal antibodies while hospitalized. I was hospitalized for 10 days total. I was ill for 28 days. I am still having to use oxygen 3 months after being released from the hospital, and have lingering low grade fevers, altered sense of taste, and migraines.
Pt recv vax on 11/6/98; on 11/11/98 pt exp wheezing & shortness of breath; tx=Benadryl
fever 102+ 7AM - 5PM, headache 7AM - 5PM, bodyache 7AM - 5PM, sore shoulder - few days
Five days after second covid vaccine got bulging disk in her neck and shooting pains down right arm. Has not resolved as of today still has pain and numbness in fingertips is seeing a chiropracter regularly and symptoms improve after chiropractor treatment.
On 10/3/2018 pt received the 1st SHINGRIX vaccine. She called pharmacy 12/14/2018 and wanted to know whether or not she should get the 2nd SHINGRIX vaccine because the first vaccine caused quite significant shoulder pain. The day after the vaccine she could not move her arm due to the pain, the next day she could move it a little below the elbow and then each successive day it gradually got a little bit better. She also said that on the third day she started to notice that her teeth were chattering.  Teeth chattering could be a response to having the chills and chills are part of the symptoms that sometimes accompany flu like symptoms after a vaccine. However, she said that she did not have chills just the teeth chattering. She said that the teeth chattering went away but that sometimes now she still gets them. I am not aware that SHINGRIX can cause that side effect. She did not see her doctor about the reaction she had to the vaccine. I called the doctor's office and notified them of the patient's comments. They said that they will follow up with her.
Patient was administered first dose of Moderna vaccine, but the time window for the vaccine was beyond 12 hours after puncturing of the vial. The beyond use date and time on label was 7/7/21 11:33pm and the vaccine was given 7/8/21 12:15pm. Moderna was contacted and they stated that patient does not need to repeat the first dose and should receive second dose in 28 days as scheduled. Patient did not have any side effects and felt fine.
administered three shots from a vial left out at room temperature for roughly 20 hours; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered three shots from a vial left out at room temperature for roughly 20 hours) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009D21A and 011D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered three shots from a vial left out at room temperature for roughly 20 hours). On 30-Jun-2021, EXPIRED PRODUCT ADMINISTERED (administered three shots from a vial left out at room temperature for roughly 20 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided by reporter. No treatment medication provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up received and Consist of Dosage text and dates were added, Primary reporter information was added and consent to safety was given yes.
The day after I received the vaccination, I developed some mild swelling with a large area of redness around the injection site. My arm was sore for the first 2-3 days following the injection. The swelling went down and the large red patch went away after about 4 days. I had no symptoms from days 5-7. Then on day 8, the red area re-appeared around the injection site, and was very itchy. It also appeared welted.  The redness remained from day 8-12. Today is day 13, and the redness seems to have fully resolved.
Very sick; Chills; Fever; Nausea; Vomiting; Inappetence; Dehydrated; Weakened; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness, chills, fever, nausea, vomiting, inappetence, dehydration and weakness. On an unknown date, the outcome of the sickness, chills, fever, nausea, vomiting, inappetence, dehydration and weakness were unknown.   It was unknown if the reporter considered the sickness, chills, fever, nausea, vomiting, inappetence, dehydration and weakness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had sickness, chills, fever, nausea, vomiting, inappetence, dehydration and weakness. The patient asked should get the second vaccination.
Fever, fatigue, aches, extreme nausea, lightheadedness, large rash on the side of my face
sore arm after 2nd dose; received 2nd dose 24 days after first dose; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm after 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose 24 days after first dose) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Bee sting (Allergic to Bees), Arthritis (has arthritis in knees, hip, back, and shoulders), Shellfish allergy (get a rash or get nauseated when eat fish), Drug allergy (Patient was allergic Sulfa.), Drug allergy (Allergic to demerol) and Drug allergy (Allergic to omega XL.). Concomitant products included ATENOLOL and AMLODIPINE BESYLATE for Hypertension, PRAVASTATIN, LOSARTAN POTASSIUM and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm after 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose 24 days after first dose). At the time of the report, PAIN IN EXTREMITY (sore arm after 2nd dose) had resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2nd dose 24 days after first dose) outcome was unknown. It was reported that Recent change in status of patient historical condition was worsened. Patient did not received other vaccines given within 1 month prior to Moderna COVID-19 vaccine. No treatment details were reported. This case was linked to MOD-2022-598096 (Patient Link).
3 days later, when I woke up, my body felt like it was ran over by a dump truck. I had excruciating back pain for 3 days. My tongue is red,  and it burns when I eat. My teeth are very sensitive, very difficult to brush them.  It is now 1 week later,  and I feel lethargic. I took aspirin and it helped alleviate the pain in my back.
rash; low grade fever; headache; flu-like symptoms; really sick; coughing; phlegm; wheezing; severe respiratory issue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), ILLNESS (really sick), COUGH (coughing), PRODUCTIVE COUGH (phlegm) and WHEEZING (wheezing) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Heart disorder.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), ILLNESS (really sick), COUGH (coughing), PRODUCTIVE COUGH (phlegm), WHEEZING (wheezing) and RESPIRATORY DISORDER (severe respiratory issue). On 13-May-2021, the patient experienced RASH (rash), PYREXIA (low grade fever) and HEADACHE (headache). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), ILLNESS (really sick), COUGH (coughing), PRODUCTIVE COUGH (phlegm), WHEEZING (wheezing), RESPIRATORY DISORDER (severe respiratory issue), RASH (rash), PYREXIA (low grade fever) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include blood pressure medications and heart medication  Treatment includes Tea and emergency
A pharmacist reported that a pt received an injection of TD Toxoids Adsorbed, Purogenated and subsequently developed a fever and a "severe" local reaction. No further information was available at the date of this report. The reporter indicated that 3 pts experienced this event following receipt of this vaccine, lot 471638; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided.
left arm pain, swelling and redness fatique, headache, muscle pain, joint pain, chills, nausea and fever
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the patient was vaccinated with improperly stored VAQTA 25/0.5 (units not provided) (dose, frequency and route were not reported) lot # L023966 with an expiry of 15-MAR-2017. No concomitant medications were reported. No adverse effects were reported. This healthcare worker also inquired about the stability of M-M-R II, however, M-M-R II did not undergo a temperature excursion and is not included int his adverse event (AE). There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient said she got Hives all over her body including inside her eyes and cough  1 week after she received her first dose Pfizer COVID-19 vaccine.  Reported day 5/18/21
Numbness in both arms from shoulder down lasting ~15-20 mins, body weakness afterwards, shaking of both hands, hands with muscle rigidity. Following these, experienced bad diarrhea, abdominal cramps, lasting also for about 15 mins. After patient took a warm shower and tried to relax, she felt better and most symptoms subsided.
Pt was seen 9/19/11 cc of right arm swelling, redness & warm to touch. With mild itching associated on 9/16/11; day vaccine was given. Sxs increased the following day.
Dizziness first evening. Next morning woke with shoulder pain, trouble breathing and fatigue. Used heating pad on shoulder still having trouble breathing. Rested all day. Felt relief next day. Then had a large 2-3" itchy, red blotchy area at injection site. Itchiness lasted 3 days. Still have a bruise type area remaining but itching is gone. I have had many flu shots and NEVER had any reaction whatsoever. This is a complete mystery.
Inappropriate Reconstitution Technique/had been tilting the vaccines but not shaking them; Inappropriate dose of vaccine administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 4-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number EJ577, expiry date 13-JUN-2025) for prophylaxis.   On 23-AUG-2023, the patient received the 2nd dose of Pediarix. On 23-AUG-2023, an unknown time after receiving Pediarix, the patient experienced inappropriate preparation of medication (Verbatim: Inappropriate Reconstitution Technique/had been tilting the vaccines but not shaking them) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 24-Aug-2023 CMA stated that they noticed a solid mass in the Pediarix PFS and asked if this was normal  She stated that she checked some of the other syringes and some had them and some did not. She stated that she was speaking with a colleague who informed her that they are supposed to shake the PFS before administering.  She said that when she shook a syringe, she noticed that the mass did go away and that they had been tilting the vaccines but not shaking them. The vaccine administration facility was the same as primary reporter. The patient received vaccine which was not shook properly, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
24 hours post vaccine developed itchy legs. Over the course of 5 days both thighs developed red hot blotchy rash that burns and itches, radiating heat. Not helped by benedryl, Zyrtec, hydrocortisone.
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On unspecified date, the patients were vaccinated with improperly stored ROTATEQ (dose and route unknown, lot # L039141, expiration date: 16-AUG-2017). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
1145am B/P 150/80 P 60 - states feels like "fluid coming in head". and sensation in month like fluid in mouth c/o nausea 1150am 140/80 no nausea. States feels like much better.